This study will aim to determine whether ingesting creatine nitrate (CrN) at higher doses will differentially affect hemodynamic variables compared to a placebo.

This study will examine the short-term (7 day) characteristics of ingesting creatine nitrate (CrN) compared to placebo on Chem-15 blood safety, heart rate, blood pressure, heart rate and blood pressure reactivity and self-reported side effects.

Inclusion Criteria:

• Apparently healthy
• At least 6 months immediate prior history of resistance training including bench press and leg press or squat

Exclusion Criteria:

• A history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease
• Use of prescription medication (birth control is allowed)
• Pregnant or nursing or plan to become pregnant during the next month
• Creatine or nitrate use in the last eight weeks
• History of smoking
• History of drinking (i.e., 12 drinks per week or more)
• Use of nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen (Advil, Motrin, Nuprin, etc.), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene)